Navigating Amorphous Calcium Carbonate Therapies: Eden Ben from Amorphical in Conversation with PharmaShots

Shots: ACC therapies introduce a novel treatment approach by modulating local pH, promoting bone remodeling, and reducing inflammation, with potential applications in osteoarthritis, calcium deficiencies, late-stage cancers, and bone disorders. Amorphical’s AMOR-18 showed encouraging results in an interim Phase II clinical trial involving COVID-19 patients. PharmaShots speaks with Eden Ben, CEO of Amorphical, to discuss…

BySaurabh ChaubeySeptember 22, 2025

THOUGHTSPOT

Clinical Trial to Study Effectiveness of Cancer Treatment Administered 2024

There are tons of clinical trials taking place at this moment. It’s a nasty disease and it’s important to figure out different ways to diagnose it, treat it, and, if possible, prevent it. 2024 brings on innovations in this field.It can probably shed light on how cancer can become more treatable and not such…

ByJack TurnerJune 20, 2024

THOUGHTSPOT

The New Normal and Covid-19 Vaccine Development

Since the virus outbreak in China, all eyes are on the most awaited Covid-19 vaccine offering a glimmer of hope. Abide by social distancing, wearing a mask, and frequent hand washing - until we have a vaccine. This new mantra amidst all misery has created hope in the hearts of many. We have to accept…

BySenior EditorAugust 5, 2020

Navigating Amorphous Calcium Carbonate Therapies: Eden Ben from Amorphical in Conversation with PharmaShots

Clinical Trial to Study Effectiveness of Cancer Treatment Administered 2024

The New Normal and Covid-19 Vaccine Development

Contact US

OUR INFORMATION

FOLLOW US